1111 – 1120 of 1407
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Hospital admission rates among men and women with symptoms of chronic bronchitis and airflow limitation corresponding to the GOLD stages of chronic obstructive pulmonary disease - A population-based study
(
- Contribution to journal › Article
-
Mark
Treatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA(2)LEN
(
- Contribution to journal › Scientific review
-
Mark
Airway inflammation: An important marker of control for asthma guidelines? Reply
(
- Contribution to journal › Letter
-
Mark
A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma
(
- Contribution to journal › Article
-
Mark
Symbicort SMART - Effective treatment at a lower cost
(
- Contribution to journal › Published meeting abstract
-
Mark
Achieving asthma control in practice: Understanding the reasons for poor control
(
- Contribution to journal › Scientific review
-
Mark
Increased Prevalence of Multiple Sclerosis Among COPD Patients and Their First-Degree Relatives: A Population-based Study.
(
- Contribution to journal › Article
-
Mark
Antibacterial chemokines - actors in both innate and adaptive immunity.
(
- Contribution to journal › Article
-
Mark
Specific nasal symptoms and symptom-provoking factors may predict increased risk of developing COPD.
(
- Contribution to journal › Article
-
Mark
The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial
(
- Contribution to journal › Article